Transcriptional down-regulation of


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
09 04 2019
Historique:
received: 12 12 2018
accepted: 01 04 2019
entrez: 10 4 2019
pubmed: 10 4 2019
medline: 27 2 2020
Statut: epublish

Résumé

HIV +Elite and Viremic controllers (EC/VCs) are able to control virus infection, perhaps because of host genetic determinants. We identified 16% (21 of 131) EC/VCs with CD4 +T cells with resistance specific to R5-tropic HIV, reversed after introduction of

Identifiants

pubmed: 30964004
doi: 10.7554/eLife.44360
pii: 44360
pmc: PMC6456299
doi:
pii:

Substances chimiques

CCR2 protein, human 0
CCR5 protein, human 0
Receptors, CCR2 0
Receptors, CCR5 0

Banques de données

GEO
['GSE122321', 'GSE122322', 'GSE122323']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIH HHS
ID : S10 OD018521
Pays : United States
Organisme : NIH HHS
ID : P30AI050409
Pays : United States
Organisme : NIDA NIH HHS
ID : DP1DA036463
Pays : United States

Déclaration de conflit d'intérêts

EG, PR, UI, RL, SM, AC, JP, TL, VM, DR, BW, SD, RS No competing interests declared

Références

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8695-700
pubmed: 12060701
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Virology. 2002 Dec 20;304(2):246-64
pubmed: 12504566
AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1509-19
pubmed: 9840284
Lancet. 1997 Mar 29;349(9056):922-3
pubmed: 9093257
Immunity. 2007 Sep;27(3):406-16
pubmed: 17892849
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Elife. 2019 Apr 09;8:
pubmed: 30964004
Transcription. 2016 May 26;7(3):57-62
pubmed: 27105138
Clin Infect Dis. 2010 Jul 15;51(2):233-8
pubmed: 20550452
Nat Methods. 2011 Jun;8(6):469-77
pubmed: 21623353
J Virol. 2015 May;89(10):5502-14
pubmed: 25740989
J Biol Chem. 1997 Dec 5;272(49):30662-71
pubmed: 9388201
Nat Med. 1996 Apr;2(4):412-7
pubmed: 8597950
J Exp Med. 2006 May 15;203(5):1357-69
pubmed: 16682496
EMBO Rep. 2009 Nov;10(11):1213-9
pubmed: 19834511
AIDS. 2004 May 21;18(8):1109-16
pubmed: 15166526
Sci Rep. 2017 Mar 22;7(1):232
pubmed: 28331180
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84
pubmed: 22006329
Nat Protoc. 2010 Jun;5(6):1033-41
pubmed: 20539279
AIDS. 2007 May 11;21(8):1043-5
pubmed: 17457100
J Virol. 1998 Jan;72(1):876-81
pubmed: 9420304
AIDS Res Hum Retroviruses. 2004 Nov;20(11):1210-22
pubmed: 15588343
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4762-71
pubmed: 26307764
Lancet. 1998 Sep 12;352(9131):866-70
pubmed: 9742978
Nat Genet. 2016 Oct;48(10):1193-203
pubmed: 27526324
Genes Dev. 2006 Nov 1;20(21):2922-36
pubmed: 17079683
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14658-63
pubmed: 26553974
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
Curr Opin Immunol. 2000 Apr;12(2):206-9
pubmed: 10712937
Oncogene. 2003 Mar 20;22(11):1638-52
pubmed: 12642867
J Biol Chem. 1998 Jan 2;273(1):309-14
pubmed: 9417081
Blood. 2011 Jul 28;118(4):955-64
pubmed: 21642597
Clin Infect Dis. 2005 Oct 1;41(7):1053-6
pubmed: 16142675
Yale J Biol Med. 2017 Jun 23;90(2):245-259
pubmed: 28656011
Blood. 2007 Jun 15;109(12):5380-9
pubmed: 17332243
J Virol. 2005 Nov;79(22):14169-78
pubmed: 16254352
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Cell. 1996 Aug 9;86(3):367-77
pubmed: 8756719
Science. 1996 May 10;272(5263):872-7
pubmed: 8629022
Immunity. 2014 Feb 20;40(2):274-88
pubmed: 24530056
Nat Rev Immunol. 2003 Nov;3(11):900-11
pubmed: 14668806
J Virol. 2005 Sep;79(18):11677-84
pubmed: 16140745
Nat Genet. 2007 Mar;39(3):311-8
pubmed: 17277777
HIV Med. 2007 Mar;8(2):96-104
pubmed: 17352766
BMC Med Genomics. 2013 May 01;6:15
pubmed: 23635305
J Clin Invest. 2011 Apr;121(4):1549-60
pubmed: 21403397
Mol Cell Biol. 1996 Oct;16(10):5811-20
pubmed: 8816495
Cell Cycle. 2011 Oct 1;10(19):3213-4
pubmed: 21926474
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):172-7
pubmed: 9419348
J Med Virol. 2009 Oct;81(10):1681-90
pubmed: 19697415
Nature. 1996 Aug 22;382(6593):722-5
pubmed: 8751444
Cell. 2005 Jan 28;120(2):169-81
pubmed: 15680324
Ann Intern Med. 1997 Nov 15;127(10):882-90
pubmed: 9382366
J Virol. 2007 Mar;81(5):2508-18
pubmed: 17151109
Am J Cancer Res. 2017 Apr 01;7(4):869-880
pubmed: 28469959

Auteurs

Elena Gonzalo-Gil (E)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States.

Patrick B Rapuano (PB)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States.

Uchenna Ikediobi (U)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States.

Rebecca Leibowitz (R)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States.

Sameet Mehta (S)

Yale Center for Genome Analysis Bioinformatics group, Yale University School of Medicine, New Haven, United States.

Ayse K Coskun (AK)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States.

J Zachary Porterfield (JZ)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States.

Teagan D Lampkin (TD)

Infectious Diseases Section, Dallas VA Medical Center, Dallas, United States.

Vincent C Marconi (VC)

Atlanta VA Medical Center, Emory University School of Medicine, Atlanta, United States.

David Rimland (D)

Atlanta VA Medical Center, Emory University School of Medicine, Atlanta, United States.

Bruce D Walker (BD)

Ragon Institute of MGH, MIT and Harvard University, Cambridge, United States.

Steven Deeks (S)

Department of Medicine, University of California San Francisco, San Francisco, United States.
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States.

Richard E Sutton (RE)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH